Antibacterial Agents TRIZ Cases

AgrA antagonist compounds block the phosphoryl-binding pocket to inhibit virulence factor synthesis, reducing bacterial pathogenicity without affecting growth.

CRISPR bacteriophages selectively reduce pathogenic bacterial loads in the microbiome, restoring immune system function for effective cancer treatment.

Fusion protein vaccine induces strong Th17 and T-cell responses, addressing insufficient serotype coverage in existing pneumococcal immunizations.

Rv3615c peptides detect Mycobacterium tuberculosis infection via T-cell recognition, eliminating false positives from BCG vaccination.

Drug fusions merge polypeptides with albumin-binding domains to reduce rapid elimination and prolong serum half-life.

2′-fucosyllactose oligosaccharide restores intestinal α1-2-fucosylation, reducing harmful bacterial colonization and ethanol-induced liver injury.

High-affinity anti-GDF15 antibodies neutralize growth differentiation factor 15 activity, reversing cancer-associated cachexia and weight loss.

Small peptides with Asp-Ser-Ser motifs target demineralized tissues, solving the trade-off between calcium availability and binding specificity.

Ethanol precipitation recovers Inter-alpha-Inhibitor proteins from discarded plasma fractions, addressing shortages caused by limited raw plasma availability.

Thermoresponsive chitosan gel adheres to the urethra during intercourse, blocking bacterial entry without systemic antibiotics.

Glyco-substituted chlorin conjugates penetrate complex media like serum to inactivate resistant Gram-positive and Gram-negative bacteria via photo-oxidation.

Nitric oxide treatment disrupts biofilm defenses via reactive species, avoiding toxic agent harm.

Modifying the macrolide core with specific amino groups at the 4'' position enhances acid stability and reduces acute toxicity while maintaining high efficacy.

Fluorogenic peptide substrates enable rapid detection of plague protease activity, bypassing slow culture methods to identify Yersinia pestis infections.

Conjugating cocaine derivatives to adenovirus capsid proteins overcomes poor immunogenicity and reduces brain drug levels.

Solid copper sulfate and clay composition resists moisture washout, preventing frequent reapplication of antimicrobial hoof treatments.

Antisense nucleic acids reduce specific bacterial gene activity to sensitize cells for antibiotic treatment.

Pyrazolopyrimidine compounds selectively induce human interferon alpha over tumor necrosis factor alpha to treat allergic diseases and infectious conditions.

SA-MAPS immunogenic composition links polysaccharides to antigens via affinity binding pairs.

Polyglyceryl ester surfactants reduce viscosity in aqueous organic peroxide dispersions, enabling pumpable high-concentration formulations.

One-pot synthesis of acetimidamide antimicrobials overcomes microbial resistance and low yield challenges.

Poxviral vectors fuse antigenic proteins with invariant chains to enhance protective immunity against pathogens.

Antimicrobial peptides conjugate antigens to outer membrane vesicles, bypassing detergent extraction that compromises stability.

A zinc compound formulation paired with glycerine monoalkyl ether delivers broad-spectrum antimicrobial activity at low concentrations.

Compounds degrade estrogen receptors via the ubiquitin-proteasome pathway.

Specific antibodies detect Panton-Valentine leukocidin toxin directly, bypassing time-consuming PCR steps and specialized facility requirements.

Activating transposon increases gene transcription to identify essential targets, resolving low mutant pool representation in conventional Tn-seq.

Avibactam synthesis uses disposable catalysts and one-pot reactions to streamline production.

Dual modified T cell populations resolve on-target off-tumor toxicities while sustaining CAR-T cell survival in the tumor microenvironment.

Modulating miR-124 in mammalian trophoblast stem cells generates glucose-sensitive pancreatic progenitors.

Annexin V stabilizes phage suspensions against aggregation, enabling high concentrations for rapid bacterial lysis.

Parenteral E. coli H7 flagella immunogen reduces O157:H7 colonization and shedding, addressing the lack of effective bovine vaccines.

Vitamin D carrier beads provide sustained antibiotic release at the wound site, reducing systemic side effects and resistance development.

Aminobenzamide derivatives combat resistant parasites by modifying chemical structures to maintain efficacy and reduce disease transmission risks.

Bacteriophage ΦCJ23 lyses avian pathogenic Escherichia coli to resolve antibiotic resistance and residue issues in poultry production.

Peptides targeting the sliding clamp address antimicrobial resistance while managing design complexity through parameter changes.

Extracted yeast polysaccharides resist E. coli invasion to treat chronic inflammatory bowel disease without surgical intervention or drug side effects.

Electroporating antigen-presenting cells with mRNA encoding immunostimulatory factors restores lost cytokine secretion and overcomes T-cell tolerance.

Chromosomal integration of a nontoxic alpha-toxin mutein in an attenuated Clostridium perfringens strain eliminates repeated booster shots and safety risks.

Segmenting the active ingredient layer from the binder prevents performance degradation over time while enabling easy application without specialized tools.

Disrupting axial interactions converts flagellin into a monomeric state that amplifies immune responses without forming toxic filaments.

A chimeric polypeptide combines a muralytic domain with a membrane traversing domain to degrade bacterial cell walls.

Small molecule compounds modulate ferroptosis pathways to selectively destroy RAS-mutant tumor cells while reducing reactive oxygen species levels.

A multi-protein vaccine elicits protective immunity to reduce acute exacerbations of chronic obstructive pulmonary disease caused by Haemophilus influenzae.